Streetbeat News

Partnerships

MMM

SYNX

Silynxcom Ltd. (SYNX) and 3M PELTOR have announced an expansion of their collaboration to include the latest Peltor ComTac VIII Headset in their mutual conversion distributor agreement. This partnership aims to deliver advanced tactical communication solutions, integrating Silynxcom's systems with Peltor's headsets for enhanced operational effectiveness.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 1:03 pm

DOMA

SGRP

UPS

Doma shares surged 40% following a merger announcement with TRG, going private at $6.29/share. SPAR Group's Q4 EPS rose to $0.11 from $0.08 YoY, with sales of $65.10M surpassing estimates. UPS shares increased by 2.28% after securing an air cargo contract with the United States Postal Service.

Portfolio Pulse from ryanfaloona@benzinga.com

April 01, 2024 | 12:55 pm

OPTX

Syntec Optics (NASDAQ:OPTX), a key supplier in scientific and technical instruments, announced receiving new orders for a high-resolution, wide-field-of-view, innovative freeform prism subsystem for defense head-up microdisplays. These orders, scheduled for delivery in 2024, add to existing orders for other microdisplay optics versions. The company has been involved in the development and production of these lightweight freeform prism subsystems for over a decade, aimed at enhancing situational awareness for aviation pilots. The US defense is actively fielding these optical systems, which integrate electronics by OEMs to generate augmented reality overlays on OLED micro-displays.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:53 pm

WLDS

Wearable Devices Ltd. (NASDAQ:WLDS) has signed a reseller agreement with WisePlus to expand its licensing program in South Korea and China. This partnership allows WisePlus to resell Wearable Devices' Mudra Developer Kit (MDK), enhancing touchless sensing wearables' development and integration. The collaboration aims to leverage WisePlus' regional expertise, offering local support and customization for enterprises. The MDK, designed for OEMs and developers, supports creating custom gestures for various applications, promising innovation in the XR market and beyond.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:50 pm

ARE

Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced an early 6-year lease renewal with insitro at the Alexandria Center for Advanced Technologies in South San Francisco. This renewal, extending through August 31, 2034, for 143,188 RSF, underscores insitro's commitment to its headquarters and R&D site. The deal highlights the growing demand for AI-enhanced laboratory space for drug discovery and development. Alexandria's strategic presence in South San Francisco since 1998 has positioned it as a key enabler for life science companies, with nearly 3.4 million RSF in operation.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:36 pm

INCY

Incyte (NASDAQ:INCY) and China Medical System Holdings Limited (CMS) have entered into a collaboration and license agreement for the development and commercialization of povorcitinib, an oral JAK1 inhibitor, in Mainland China, Hong Kong, Macau, Taiwan, and Southeast Asia. Povorcitinib is being evaluated for various autoimmune and inflammatory dermatologic diseases. Under the agreement, CMS will make an upfront payment to Incyte, with Incyte eligible for additional milestones and royalties on net sales in CMS' territory.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:35 pm

CG

TEVA

Teva Pharmaceutical Industries Ltd. (TEVA) and Launch Therapeutics have entered a clinical collaboration to accelerate the development of Teva's Dual-Action Asthma Rescue Inhaler (TEV-‘248). Additionally, Teva and Abingworth, part of Carlyle (CG), announced a strategic development funding agreement providing Teva up to $150 million to support the TEV-‘248 program. This collaboration aims to expedite the clinical research program, with Launch Therapeutics leading the operational execution of clinical trials. Teva retains responsibility for manufacturing, U.S. regulatory interactions, and commercialization. The funding from Abingworth will be recognized by Teva as a reduction in R&D expenses, and Abingworth is eligible for payments based on sales if TEV-‘248 receives FDA approval.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:33 pm

FRSX

Foresight Autonomous Holdings Ltd. (FRSX) subsidiary, Eye-Net Mobile Ltd., has entered a three-way proof-of-concept project with a leading Japanese insurance company and a dashcam manufacturer to integrate Eye-Net's technology into dashcams. This collaboration aims to enhance road safety by providing drivers with advanced tools to prevent accidents, potentially leading to reduced insurance costs and improved claim processes.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:30 pm

BLDP

Ballard Power Systems (NASDAQ:BLDP) (TSX:BLDP) announced a Long Term Supply Agreement with Solaris Bus & Coach for 1,000 hydrogen fuel cell engines through 2027, marking the company's largest order. The engines will power Solaris buses across Europe, supporting the transition to zero-emission public transport. The order includes after-market and extended warranty services, with deliveries starting in 2024. This agreement strengthens Ballard's position in the European transit bus market and supports the decarbonization of urban fleets.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:16 pm

AMTX

Aemetis, Inc. (NASDAQ:AMTX) has implemented the Microsoft Dynamics ERP system to support its operations and expansion projects in the U.S. and India. This move is part of Aemetis' Five Year Plan, aiming for over $1.9B in revenues and $645M in EBITDA by the fifth year. The ERP system will support various projects, including the Aemetis Biogas business, the India biodiesel business IPO, the Riverbank sustainable aviation fuel production plant, the Riverbank carbon sequestration project, and the Keyes ethanol plant upgrade.

Portfolio Pulse from Benzinga Newsdesk

April 01, 2024 | 12:12 pm